Biocartis Group NV Sustainability Reports
A former holding company that previously engaged in the development and commercialization of molecular diagnostics solutions for oncology. Following the enforcement of security claims by its creditors, its main operating business was transferred out, and the holding company entered judicial dissolution.
Sector: Manufacturing
Country: Belgium
Exchange: Euronext Brussels
ISIN: BE0974281132
9 reports from 2015 to 2022